According to a CNBC interview last week the product is protected via trade secrets.  People know what&#x27;s in it, but not how to make it.  And it&#x27;s some weird stuff (I think pituitary glands from pigs or something equally weird are key components - not sure there&#x27;s a lot of open-source knowledge on how to deal with that ingredient pipeline.)<p>The CEO&#x27;s pitch was that they believe the drug is useful in more roles than it&#x27;s currently used for, so they&#x27;re taking the increased money to perform the studies required to allow the drug to be used to treat more diseases for which there is no alternative.<p>And right now this is a last-ditch drug - it&#x27;s used once all other therapies have failed.<p>So they&#x27;re trying to increase marketshare by doing expensive studies, which is why this drug is still produced and where the money is going.<p>At least according to the CEO, and my memory.